ExonSkipAD provides the functional genomic landscape of exon skipping events in Alzheimer's disease

Exon skipping (ES), the most common alternative splicing event, has been reported to contribute to diverse human diseases due to the loss of functional domains/sites or frameshifting of the open reading frame (ORF) and noticed as therapeutic targets. Accumulating transcriptomic studies of aging brains show the splicing disruption is a widespread hallmark of neurodegenerative diseases such as Alzheimer's disease (AD). Here, we built ExonSkipAD, the ES annotation database aiming to provide a resource/reference for functional annotation of ES events in AD and identify therapeutic targets in exon units. We identified 16 414 genes that have ~156 K, ~ 69 K, ~ 231 K ES events from the three representative AD cohorts of ROSMAP, MSBB and Mayo, respectively. For these ES events, we performed multiple functional annotations relating to ES mechanisms or downstream. Specifically, through the functional feature retention studies followed by the open reading frames (ORFs), we identified 275 important cellular regulators that might lose their cellular regulator roles due to exon skipping in AD. ExonSkipAD provides twelve categories of annotations: gene summary, gene structures and expression levels, exon skipping events with PSIs, ORF annotation, exon skipping events in the canonical protein sequence, 3'-UTR located exon skipping events lost miRNA-binding sites, SNversus in the skipped exons with a depth of coverage, AD stage-associated exon skipping events, splicing quantitative trait loci (sQTLs) in the skipped exons, correlation with RNA-binding proteins, and related drugs & diseases. ExonSkipAD will be a unique resource of transcriptomic diversity research for understanding the mechanisms of neurodegenerative disease development and identifying potential therapeutic targets in AD. Significance AS the first comprehensive resource of the functional genomics of the alternative splicing events in AD, ExonSkipAD will be useful for many researchers in the fields of pathology, AD genomics and precision medicine, and pharmaceutical and therapeutic researches.

[1]  Thomas R. Gingeras,et al.  STAR: ultrafast universal RNA-seq aligner , 2013, Bioinform..

[2]  Lan Jin,et al.  Biological basis for restriction of microRNA targets to the 3' untranslated region in mammalian mRNAs. , 2009, Nature structural & molecular biology.

[3]  Avi Ma'ayan,et al.  Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool , 2013, BMC Bioinformatics.

[4]  Benjamin A. Logsdon,et al.  The Mount Sinai cohort of large-scale genomic, transcriptomic and proteomic data in Alzheimer's disease , 2018, Scientific Data.

[5]  S. Lovestone,et al.  Amyloid β synaptotoxicity is Wnt-PCP dependent and blocked by fasudil , 2018, Alzheimer's & Dementia.

[6]  Zhongming Zhao,et al.  An integrative functional genomics framework for effective identification of novel regulatory variants in genome–phenome studies , 2018, Genome Medicine.

[7]  D. Bartel,et al.  Predicting effective microRNA target sites in mammalian mRNAs , 2015, eLife.

[8]  Yinghui Chen,et al.  Long noncoding RNAs and Alzheimer’s disease , 2016, Clinical interventions in aging.

[9]  Benjamin A. Logsdon,et al.  Gene Expression Elucidates Functional Impact of Polygenic Risk for Schizophrenia , 2016, Nature Neuroscience.

[10]  Jinping Li,et al.  Zinc Finger and X-Linked Factor (ZFX) Binds to Human SET Transcript 2 Promoter and Transactivates SET Expression , 2016, International journal of molecular sciences.

[11]  K. Jellinger,et al.  Correlation of Alzheimer Disease Neuropathologic Changes With Cognitive Status: A Review of the Literature , 2012, Journal of neuropathology and experimental neurology.

[12]  R. Hammer,et al.  ApoE Receptor 2 Controls Neuronal Survival in the Adult Brain , 2006, Current Biology.

[13]  G. Schellenberg,et al.  International Genomics of Alzheimer's Disease Project (IGAP) genome-wide association study , 2012, Alzheimer's & Dementia.

[14]  W. M. van der Flier,et al.  Protein Kinase Activity Decreases with Higher Braak Stages of Alzheimer’s Disease Pathology , 2015, Journal of Alzheimer's disease : JAD.

[15]  D. Bennett,et al.  Therapeutic correction of ApoER2 splicing in Alzheimer's disease mice using antisense oligonucleotides , 2016, EMBO molecular medicine.

[16]  Anjali J. Koppal,et al.  Supplementary data: Comprehensive modeling of microRNA targets predicts functional non-conserved and non-canonical sites , 2010 .

[17]  Eric J. Hayden,et al.  Alternative Splicing in Alzheimer’s Disease , 2015, Journal of Parkinson's disease and Alzheimer's disease.

[18]  N. Aronin,et al.  Alterations in mRNA 3' UTR Isoform Abundance Accompany Gene Expression Changes in Human Huntington's Disease Brains. , 2017, Cell reports.

[19]  Neil Buckholtz,et al.  Accelerating Medicines Partnership: Alzheimer’s Disease (AMP-AD) Knowledge Portal Aids Alzheimer’s Drug Discovery through Open Data Sharing , 2016, Expert opinion on therapeutic targets.

[20]  Gunnar Rätsch,et al.  SplAdder: identification, quantification and testing of alternative splicing events from RNA-Seq data , 2016, bioRxiv.

[21]  James A. Eddy,et al.  Human whole genome genotype and transcriptome data for Alzheimer’s and other neurodegenerative diseases , 2016, Scientific Data.

[22]  Tatiana A. Tatusova,et al.  NCBI Reference Sequences: current status, policy and new initiatives , 2008, Nucleic Acids Res..

[23]  Andrey A. Shabalin,et al.  Matrix eQTL: ultra fast eQTL analysis via large matrix operations , 2011, Bioinform..

[24]  Colin N. Dewey,et al.  RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome , 2011, BMC Bioinformatics.

[25]  P. Kim,et al.  ExonSkipDB: functional annotation of exon skipping event in human , 2019, Nucleic Acids Res..

[26]  Hans-Ulrich Klein,et al.  A multi-omic atlas of the human frontal cortex for aging and Alzheimer’s disease research , 2018, Scientific Data.

[27]  D. Dinsdale,et al.  RBM3 mediates structural plasticity and protective effects of cooling in neurodegeneration , 2014, Nature.

[28]  R. Hammer,et al.  Differential splicing and glycosylation of Apoer2 alters synaptic plasticity and fear learning , 2014, Science Signaling.

[29]  L. Kaczmarek,et al.  Amot and Yap1 regulate neuronal dendritic tree complexity and locomotor coordination in mice , 2019, PLoS biology.

[30]  Pablo Cingolani,et al.  © 2012 Landes Bioscience. Do not distribute. , 2022 .

[31]  C. Mayr,et al.  Widespread Shortening of 3′UTRs by Alternative Cleavage and Polyadenylation Activates Oncogenes in Cancer Cells , 2009, Cell.

[32]  B. Tang,et al.  MicroRNAs in Alzheimer’s Disease , 2019, Front. Genet..

[33]  H. Stefánsson,et al.  Loss-of-function variants in ABCA7 confer risk of Alzheimer's disease , 2015, Nature Genetics.

[34]  D. Geschwind,et al.  Functional and Evolutionary Insights into Human Brain Development through Global Transcriptome Analysis , 2009, Neuron.

[35]  M. Blanchette,et al.  oRNAment: a database of putative RNA binding protein target sites in the transcriptomes of model species , 2019, Nucleic Acids Res..

[36]  P. Vanderklish,et al.  Morphoregulatory functions of the RNA-binding motif protein 3 in cell spreading, polarity and migration , 2018, Scientific Reports.

[37]  The UniProt Consortium,et al.  UniProt: a worldwide hub of protein knowledge , 2018, Nucleic Acids Res..

[38]  C. Lecrux,et al.  Caspase-1 inhibition alleviates cognitive impairment and neuropathology in an Alzheimer’s disease mouse model , 2018, Nature Communications.

[39]  David S. Wishart,et al.  DrugBank: a comprehensive resource for in silico drug discovery and exploration , 2005, Nucleic Acids Res..

[40]  S. Gerstberger,et al.  A census of human RNA-binding proteins , 2014, Nature Reviews Genetics.

[41]  C. DeCarli,et al.  Myelin injury and degraded myelin vesicles in Alzheimer's disease. , 2014, Current Alzheimer research.

[42]  T. Kanekiyo,et al.  ABCA7 and Pathogenic Pathways of Alzheimer’s Disease , 2018, Brain sciences.

[43]  R. Straub,et al.  Schizophrenia risk variants influence multiple classes of transcripts of sorting nexin 19 (SNX19) , 2019, Molecular Psychiatry.

[44]  Diego Garrido-Martín,et al.  ggsashimi: Sashimi plot revised for browser- and annotation-independent splicing visualization , 2018, PLoS Comput. Biol..

[45]  R. Neve,et al.  APP-BP1 mediates APP-induced apoptosis and DNA synthesis and is increased in Alzheimer's disease brain , 2003, The Journal of cell biology.

[46]  F. LaFerla,et al.  Role of calcium in the pathogenesis of Alzheimer's disease and transgenic models. , 2007, Sub-cellular biochemistry.

[47]  S. Koushika,et al.  Neurodegeneration and microtubule dynamics: death by a thousand cuts , 2015, Front. Cell. Neurosci..

[48]  Kristel Sleegers,et al.  Genetic variations underlying Alzheimer's disease: evidence from genome-wide association studies and beyond , 2016, The Lancet Neurology.

[49]  Manolis Kellis,et al.  Conserved epigenomic signals in mice and humans reveal immune basis of Alzheimer’s disease , 2015, Nature.

[50]  Joshua D. Meisel,et al.  Inhibition of Lithium-Sensitive Phosphatase BPNT-1 Causes Selective Neuronal Dysfunction in C. elegans , 2016, Current Biology.